Skip to content
OptiPin app icon OptiPin
Download

GHK-Cu: the copper peptide, explained

GHK-Cu is the copper tripeptide-1 — a naturally occurring human peptide that binds copper and declines with age, used for decades in skincare and, more recently, injected by the peptide community. The honest headline: its topical evidence is genuinely strong; its injectable evidence is thin. This page keeps that split explicit, plus why the solution is blue, the regulatory status (cosmetic-legal, injectable not approved), the half-life, the reconstitution math for its larger mg-scale vials, storage, and how to track it. It is not dosing or sourcing advice.

Status — as of June 2026
Cosmetic-legal topically; injectable not approved. As "Copper Tripeptide-1," GHK-Cu is an established, legal cosmetic ingredient in topical skincare. As an injectable drug it is not FDA-approved and is sold as a "research chemical." Its injectable compounding status is in transition — restricted under 503A Category 2 in 2023, with removal of injectable GHK-Cu announced for 2026 and an FDA advisory-committee review slated before February 2027. Unlike GH secretagogues, GHK-Cu is not explicitly named on the WADA list (though catch-all categories could apply). Nothing here is a recommendation to inject it.
Class
Copper tripeptide
Studied for
Skin / healing
Half-life
~30–60 min (limited)
Status
Cosmetic-legal · injectable research
TL;DR

What GHK-Cu is

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK) — three amino acids (glycine, histidine, lysine) bound to a copper ion. It is a naturally occurring human peptide, first isolated from plasma in 1973, also found in saliva and urine. Its plasma level declines with age (roughly 200 ng/mL at age 20 down to ~80 ng/mL by 60), which is the usual rationale offered for its regenerative role. Its cosmetic-ingredient name is Copper Tripeptide-1.

The evidence split — topical vs injectable (read this)

This is the part to get right. The evidence for GHK-Cu is not one thing — it depends entirely on the route.

Topical / cosmetic — genuinely strong

Used in skincare for decades, with a real mechanistic and (modest) clinical base, mostly from Pickart & Margolina reviews and in-vitro/animal work: it accelerates wound healing and skin remodeling, stimulates collagen (I & III), elastin, glycosaminoglycans and decorin, modulates matrix metalloproteinases, and acts as an antioxidant and a safe copper-delivery vehicle. Cosmetic clinical studies (anti-wrinkle, firming, skin density) exist, though they are typically small and short. This is a legitimately evidenced topical ingredient.

Injectable / systemic — thin

The community claims for injected GHK-Cu (systemic tissue repair, hair regrowth, anti-inflammatory, "anti-aging") have little-to-no human clinical-trial evidence. They are largely extrapolated from the topical, in-vitro and animal data above. A 2025 study showing hair regrowth used topical copper peptides + microneedling, not systemic injection. The honest reading: the topical case is decent; the injectable case is unproven in humans.

The math

Injectable GHK-Cu ships as a lyophilized powder — and unlike most peptides, its vials are often larger (commonly 50 mg or 100 mg) because it is dosed at the milligram scale, not micrograms. The same reconstitution arithmetic the peptide reconstitution calculator does for any vial applies. Worked example, purely as arithmetic:

Vial label50 mg lyophilized powder
Add5 mL bacteriostatic water
Concentration50 mg ÷ 5 mL = 10 mg/mL
Per 0.1 mL1 mg — i.e. 10 units on a U-100 syringe = 1 mg
So 2 mg would be0.2 mL = 20 units

Concentration is just milligrams divided by millilitres, and units are just hundredths of a millilitre on a U-100 insulin syringe. The reconstituted solution will be a characteristic blue — that's the copper ion, the molecule's visual fingerprint. The reconstitution calculator converts vial size + water + target into exact syringe units. The milligrams above are illustrative arithmetic, not a recommended dose — commonly reported injectable patterns are ~1–2 mg/day, but no validated human injectable dose exists.

Half-life & the injection sting

Formal pharmacokinetic data is limited, especially for injection; the plasma half-life is reported as short — roughly 30–60 minutes (approximate, secondary-source). Two practical notes worth stating honestly: (1) injectable GHK-Cu solutions are acidic (pH ~3.5–4.5) and commonly sting or burn at the injection site, with transient redness or small lumps; (2) because plasma clearance is fast, claims of long-lasting systemic effect rest on tissue retention that isn't well characterized in humans.

Storage & handling

This is not a prescription, a dose, or a sourcing guide. Topical copper-peptide skincare is well established; injectable GHK-Cu is unapproved with little human evidence, and high systemic copper dosing carries a theoretical overload concern. We are not prescribers and do not recommend injecting research chemicals. Discuss any peptide with a qualified clinician.

Stacking — the "GLOW" blend

GHK-Cu is most often discussed alongside BPC-157 and TB-500 in skin and tissue-repair contexts — the popular "GLOW" blend is GHK-Cu + BPC-157 + TB-500. This is community practice, not clinical guidance; none of the three is FDA-approved for human therapy. In OptiPin a blend like this is tracked as separate compounds, each with its own schedule, dose log and vial inventory.

Tracking GHK-Cu in OptiPin

If you are tracking a copper-peptide protocol, OptiPin treats it like any other entry — without endorsing the injectable use:

Track it properly

Log doses, skin notes & vials in OptiPin

Reminders, outcome-over-dose charts, vial runout warnings, built-in reconstitution math, and OptiInsight analysis — all on-device.

Download on the App Store

FAQ

Is GHK-Cu approved or legal?

Topically, yes — Copper Tripeptide-1 is a legal cosmetic ingredient. As an injectable drug it is not FDA-approved (sold as a "research chemical"); its injectable compounding status is in transition with an FDA review slated before Feb 2027. Cosmetic-legal ≠ injectable-approved.

Topical vs injectable — where's the evidence?

Topical has the strong, peer-reviewed base (wound healing, collagen/elastin, decades of use). Injectable/systemic has little-to-no human trial evidence — those claims are extrapolated from lab and animal data.

Why is it blue?

The copper. GHK-Cu is the copper(II) complex of the GHK tripeptide; the bound copper ion gives the powder and reconstituted solution their blue color.

Half-life and dosing?

Limited data; plasma half-life ~30–60 min (approximate). Commonly reported: ~1–2 mg/day injected, or 1–2% topical creams. Injection commonly stings because the solution is acidic (pH ~3.5–4.5). Not a recommendation.

Is GHK-Cu banned in sport?

Not explicitly named on the 2026 WADA list, unlike GH secretagogues. But catch-all categories (S0/S2) could apply depending on form and intent, so tested athletes should be cautious. We don't assert a specific named ban.

Educational only, not medical advice. Topical copper-peptide skincare is established; injectable GHK-Cu is unapproved with little human evidence. OptiPin does not recommend injecting research chemicals. Discuss any peptide with a qualified clinician.

Sources

Related

BPC-157 · TB-500 · Peptides guide · Peptide reconstitution calculator · Half-life visualizer · Injection technique